MilliporeSigma breaks ground on Sheboygan facility
MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany, broke ground Monday on a new Sheboygan facility that will produce a key component used in rapid diagnostic test kits, including for COVID-19 testing.
To access this post, you must purchase Premium Subscription - Daily Email and Full Website Access.